» Articles » PMID: 7011529

Graves' Ophthalmopathy

Overview
Journal Can Med Assoc J
Specialty General Medicine
Date 1981 Apr 1
PMID 7011529
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Graves' ophthalmopathy usually occurs in association with hyperthyroidism. Its occasional occurrence in the absence of thyroid disease suggests, however, that it may be a separate autoimmune disorder. While the evidence supporting an autoimmune pathogenesis is considerable for the ophthalmopathy, it is not so impressive as that for Graves' hyperthyroidism: orbital antibodies have not been convincingly demonstrated and autoantigens have not been identified. On the other hand, in patients with Graves' ophthalmopathy the orbital tissues and eye muscle membranes are infiltrated with lymphoid cells and show evidence of cell-mediated immune reactions. Although there is some evidence that binding of thyroid stimulating hormone fragments and thyroglobulin-antithyroglobulin immune complexes to eye muscle membranes may be important in the pathogenesis of the ophthalmopathy, this needs to be confirmed. The mechanism for the association of hyperthyroidism and ophthalmopathy is unknown, but the association likely reflects an influence of thyroid hormones on the immune system. In view of the autoimmune pathogenesis the logical treatment of Graves' ophthalmopathy appears to be immunosuppression.

Citing Articles

Thyroid associated ophthalmopathy - a review.

Mallika P, Tan A, Aziz S, Syed Alwi S, Chong M, Vanitha R Malays Fam Physician. 2015; 4(1):8-14.

PMID: 25606151 PMC: 4170380.


A musculoskeletal model of low grade connective tissue inflammation in patients with thyroid associated ophthalmopathy (TAO): the WOMED concept of lateral tension and its general implications in disease.

Moncayo R, Moncayo H BMC Musculoskelet Disord. 2007; 8:17.

PMID: 17319961 PMC: 1820789. DOI: 10.1186/1471-2474-8-17.


The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Bartley G Trans Am Ophthalmol Soc. 1994; 92:477-588.

PMID: 7886878 PMC: 1298522.


Graves' hyperthyroidism and ophthalmopathy following treatment of spontaneous hypothyroidism with levothyroxine.

Easton P, Wall J Can Med Assoc J. 1981; 125(1):65-6.

PMID: 6894884 PMC: 1862576.


Graves' ophthalmopathy and subclinical hypothyroidism: diagnostic value of the thyrotropin releasing hormone test.

Walfish P, Gottesman I, Baxter J Can Med Assoc J. 1982; 127(4):291-4.

PMID: 6807523 PMC: 1861864.


References
1.
Bolonkin D, Tate R, Luber J, Kohn L, Winand R . Experimental exophthalmos. Binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes. J Biol Chem. 1975; 250(16):6516-21. View

2.
Fakhri O, Hobbs J . Detection of antibodies which can cooperate with lymphocytes. Lancet. 1972; 2(7774):403-6. DOI: 10.1016/s0140-6736(72)91799-0. View

3.
Mullin B, Levinson R, Friedman A, Henson D, Winand R, Kohn L . Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology. 1977; 100(2):351-66. DOI: 10.1210/endo-100-2-351. View

4.
Burrow G, Mitchell M, HOWARD R, Morrow L . Immunosuppressive therapy for the eye changes of Graves' disease. J Clin Endocrinol Metab. 1970; 31(3):307-11. DOI: 10.1210/jcem-31-3-307. View

5.
Brownlie B, Newton O, Singh S . Ophthalmopathy associated with primary hypothyroidism. Acta Endocrinol (Copenh). 1975; 79(4):691-9. DOI: 10.1530/acta.0.0790691. View